Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Tinoco

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancers|May 25, 2024
Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated SarcomasRohit Raj, Han Gil Kim, Menglin Xu, et al.
Cancers|March 28, 2025
Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent AdvancesSahana Aiyer, Tae-Hee Kim, Katharine Collier, et al.
The Oncologist|March 11, 2023
Emerging Trends in Immunotherapy for Adult SarcomasMarium Husain, Luxi Chen, David Liebner, et al.
Surgical Oncology Insight|March 20, 2026
Association between area deprivation index (ADI) and initial treatment among patients with desmoid tumors<sup>☆</sup>Alexandra G Lopez-Aguiar, Menglin Xu, Han Gil Kim, et al.
Future Oncology (London, England)|February 21, 2024
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USACharles Dharmani, Oluwatosin Fofah, Eric Wang, et al.
Journal of Surgical Oncology|July 17, 2024
Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response ratesLuke V Selby, Emma Clark, James L Chen, et al.
BMC Cancer|April 7, 2023
Clinical markers of immunotherapy outcomes in advanced sarcomaMarium Husain, Dionisia Quiroga, Han Gil Kim, et al.
Plos One|September 15, 2015
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma CellsLuyuan Li, Ana C Paz, Breelyn A Wilky, et al.
BMC Cancer|June 7, 2020
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysisDionisia Quiroga, David A Liebner, Jennifer S Philippon, et al.
Annals of Surgical Oncology|June 17, 2023
Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort StudyLuke V Selby, Emma C Clark, David A Liebner, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancers|May 25, 2024
Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated SarcomasRohit Raj, Han Gil Kim, Menglin Xu, et al.
Cancers|March 28, 2025
Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent AdvancesSahana Aiyer, Tae-Hee Kim, Katharine Collier, et al.
The Oncologist|March 11, 2023
Emerging Trends in Immunotherapy for Adult SarcomasMarium Husain, Luxi Chen, David Liebner, et al.
Surgical Oncology Insight|March 20, 2026
Association between area deprivation index (ADI) and initial treatment among patients with desmoid tumors<sup>☆</sup>Alexandra G Lopez-Aguiar, Menglin Xu, Han Gil Kim, et al.
Future Oncology (London, England)|February 21, 2024
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USACharles Dharmani, Oluwatosin Fofah, Eric Wang, et al.
Journal of Surgical Oncology|July 17, 2024
Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response ratesLuke V Selby, Emma Clark, James L Chen, et al.
BMC Cancer|April 7, 2023
Clinical markers of immunotherapy outcomes in advanced sarcomaMarium Husain, Dionisia Quiroga, Han Gil Kim, et al.
Plos One|September 15, 2015
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma CellsLuyuan Li, Ana C Paz, Breelyn A Wilky, et al.
BMC Cancer|June 7, 2020
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysisDionisia Quiroga, David A Liebner, Jennifer S Philippon, et al.
Annals of Surgical Oncology|June 17, 2023
Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort StudyLuke V Selby, Emma C Clark, David A Liebner, et al.
Pageof 6